Search International and National Patent Collections

1. (WO2010124218) GENETIC VARIANTS IN IL-6, P53, MMP-9 AND CXCR PREDICT CLINICAL OUTCOME IN PATIENTS WITH CANCER TREATED WITH ANTI-VEGF THERAPY

Pub. No.:    WO/2010/124218    International Application No.:    PCT/US2010/032255
Publication Date: Fri Oct 29 01:59:59 CEST 2010 International Filing Date: Sat Apr 24 01:59:59 CEST 2010
IPC: C12Q 1/68
A61K 39/395
Applicants: UNIVERSITY OF SOUTHERN CALIFORNIA
LENZ, Heinz-Josef
Inventors: LENZ, Heinz-Josef
Title: GENETIC VARIANTS IN IL-6, P53, MMP-9 AND CXCR PREDICT CLINICAL OUTCOME IN PATIENTS WITH CANCER TREATED WITH ANTI-VEGF THERAPY
Abstract:
The invention provides compositions and methods for determining the likelihood of response or survival of cancer patients treated with anti-VEGF therapy. After determining if a patient is likely to be successfully treated, the invention also provides methods for treating the patients.